Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000187114 | SCV000240689 | uncertain significance | not specified | 2014-11-18 | criteria provided, single submitter | clinical testing | c.794_796delCCT: p.Ser265del (S265del) in exon 7 of the CLN6 gene (NM_017882.2) The normal sequence with the bases that are deleted in braces is: TCCT{CCT}TCGC. The c.794_796delCCT variant has been reported previously in an individual with late-infantile neuronal ceroid lipofuscinosis (Sharp et al., 2003). The c.794_796delCCT variant results in an in-frame deletion of a single Serine residue at a conserved position in the seventh transmembrane domain of the CLN6 protein (Kousi et al., 2012). However, this deletion is not expected to result in protein truncation or nonsense-mediated mRNA decay. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in PME-EPI,CHILD-EPI panel(s). |
Genetic Services Laboratory, |
RCV000195031 | SCV000247045 | pathogenic | Ceroid lipofuscinosis, neuronal, 6A | 2015-05-11 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000727479 | SCV000708915 | uncertain significance | not provided | 2017-06-13 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000989353 | SCV001139644 | pathogenic | Neuronal ceroid lipofuscinosis | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000989353 | SCV001410001 | pathogenic | Neuronal ceroid lipofuscinosis | 2024-01-22 | criteria provided, single submitter | clinical testing | This variant, c.794_796del, results in the deletion of 1 amino acid(s) of the CLN6 protein (p.Ser265del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs768422260, gnomAD 0.01%). This variant has been observed in individuals with neuronal ceroid lipofuscinosis type 6 (PMID: 19135028, 19520283, 30705896, 31029456). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 205182). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on CLN6 function (PMID: 15265688). For these reasons, this variant has been classified as Pathogenic. |
Centre for Inherited Metabolic Diseases, |
RCV000195031 | SCV001571377 | pathogenic | Ceroid lipofuscinosis, neuronal, 6A | 2021-04-13 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000727479 | SCV001713713 | uncertain significance | not provided | 2019-04-07 | criteria provided, single submitter | clinical testing | |
Kasturba Medical College, |
RCV000195031 | SCV001786701 | likely pathogenic | Ceroid lipofuscinosis, neuronal, 6A | criteria provided, single submitter | clinical testing | ||
Revvity Omics, |
RCV000727479 | SCV002023253 | likely pathogenic | not provided | 2020-11-23 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV001810435 | SCV002060242 | pathogenic | Ceroid lipofuscinosis, neuronal, 6A; Ceroid lipofuscinosis, neuronal, 6B (Kufs type) | 2021-11-10 | criteria provided, single submitter | clinical testing | NM_017882.2(CLN6):c.794_796delCCT(S265del) is an in-frame deletion variant classified as pathogenic in the context of neuronal ceroid lipofuscinosis, CLN6-related. S265del has been observed in cases with relevant disease (PMID: 21990111, 12815591, 19135028, 29930972). Functional assessments of this variant are available in the literature (PMID: 19135028, 15265688). S265del has been observed in population frequency databases (gnomAD: AFR 0.01%). In summary, NM_017882.2(CLN6):c.794_796delCCT(S265del) is an in-frame deletion variant that has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. |
Ce |
RCV000727479 | SCV002497797 | pathogenic | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | CLN6: PP4:Strong, PM2, PM3, PM4 |
Center for Genomic Medicine, |
RCV000195031 | SCV004806445 | likely pathogenic | Ceroid lipofuscinosis, neuronal, 6A | 2024-03-25 | criteria provided, single submitter | clinical testing |